ReviewWorld journal of gastroenterology2021

Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics.

Shintaro Akiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.